Evaluation of C677T and A1298C polymorphisms of the MTHFR gene as maternal risk factors for Down syndrome and congenital heart defects
- 24 September 2009
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 149A (10) , 2080-2087
Abstract
Abnormal folate/homocysteine metabolism due to polymorphisms in genes involved in this pathway has been implicated as an etiologic factor in Down syndrome (DS). This case–control study aimed to evaluate the effect of maternal C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase (MTHFR) as risk factors for the development of DS and congenital heart defects (CHD). The distribution of these genotypic variants was similar between mothers of children with DS (n = 239) and control mothers of normal children (n = 197), but the combined genotypes 677CT or TT and 1298AA increased the risk of having offspring with DS (OR = 1.99; 95% CI 1.11–3.55). The presence of the 677T allele in case mothers resulted in a 2.07‐fold higher odds of CHD in the offspring (P < 0.01). Among the 57 mothers of CHD‐affected children with DS who carried the MTHFR 677CT or TT genotypes and did not have periconceptional folic acid intake, we observed a 2.26‐fold increased odds (95% CI 1.25–4.09) of having any CHD‐affected child with DS. Our results show that MTHFR genetic polymorphisms may be involved in the etiology of DS in our population when controlling for age. We noted a borderline significant association for the C677T polymorphism (P = 0.05). Maternal 677T allele may be associated with an increased occurrence of CHD in children with DS and we anticipate that women who carry this polymorphism would benefit from periconceptional folic acid supplementation.Keywords
This publication has 52 references indexed in Scilit:
- Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome ProjectGenetics in Medicine, 2008
- Can folic acid protect against congenital heart defects in down syndrome?Birth Defects Research Part A: Clinical and Molecular Teratology, 2006
- Methylenetetrahydrofolate reductase gene polymorphisms and their association with trisomy 21Prenatal Diagnosis, 2005
- Relationship between polymorphisms in genes involved in homocysteine metabolism and maternal risk for Down syndrome in BrazilAmerican Journal of Medical Genetics Part A, 2005
- Maternal metabolic phenotype and risk of down syndrome: Beyond geneticsAmerican Journal of Medical Genetics Part A, 2003
- Methionine synthase (MTR) 2756 (A → G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndromeAmerican Journal of Medical Genetics Part A, 2003
- Response to “genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A”American Journal of Medical Genetics, 2002
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- DNA Methylation in Folate Deficiency: Use of CpG MethylaseBiochemical and Biophysical Research Communications, 1993
- Down syndrome—a disruption of homeostasisAmerican Journal of Medical Genetics, 1983